Insider Transactions in Q2 2025 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 30
2025
|
Allan M. Fox |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+28.96%
|
-
|
|
May 30
2025
|
Jean Bennett |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+28.96%
|
-
|
|
May 30
2025
|
Argeris N Karabelas |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+28.96%
|
-
|
|
May 30
2025
|
Alexandra Glucksmann |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+28.96%
|
-
|
|
May 30
2025
|
George V Migausky |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+28.96%
|
-
|
|
May 30
2025
|
Kenneth T. Mills |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+1.58%
|
-
|
|
May 30
2025
|
David C Stump |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+28.96%
|
-
|
|
May 30
2025
|
Daniel Tasse |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+28.96%
|
-
|
|
May 30
2025
|
Jennifer Zachary |
BUY
Grant, award, or other acquisition
|
Direct |
7,768
+26.04%
|
-
|
|
May 12
2025
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
20,602
-4.16%
|
$144,214
$7.91 P/Share
|
|
May 12
2025
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
20,602
+3.99%
|
$61,806
$3.76 P/Share
|